Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine(Karolinska Institutet), André Perez‐Potti(Karolinska Institutet), Olga Rivera‐Ballesteros(Karolinska Institutet), Kristoffer Strålin(Karolinska University Hospital), Jean‐Baptiste Gorin(Karolinska Institutet), Annika Olsson(Karolinska University Hospital), Sian Llewellyn‐Lacey(University Hospital of Wales), Habiba Kamal(Karolinska University Hospital), Gordana Bogdanović(Karolinska University Hospital), Sandra Muschiol(Karolinska University Hospital), David Wullimann(Karolinska Institutet), Tobias Kammann(Karolinska Institutet), Johanna Emgård(Karolinska Institutet), Tiphaine Parrot(Karolinska Institutet), Elin Folkesson(Karolinska University Hospital), Mira Akber(Karolinska University Hospital), Lena Berglin(Karolinska University Hospital), Helena Bergsten(Karolinska University Hospital), Susanna Brighenti(Karolinska University Hospital), Demi Brownlie(Karolinska University Hospital), Marta Butrym(Karolinska University Hospital), Benedict J. Chambers(National University of General San Martín), Puran Chen(Karolinska Institutet), Martin Cornillet Jeannin(Karolinska University Hospital), Jonathan Grip(Karolinska Institutet), Angelica Cuapio Gomez(Karolinska Institutet), Lena Dillner(University Hospital of Wales), Isabel Diaz Lozano(Karolinska Institutet), Majda Dzidic(Karolinska University Hospital), Malin Flodström‐Tullberg(Karolinska Institutet), Anna Färnert, Hedvig Glans, Alvaro Haroun-Izquierdo, Elizabeth Henriksson, Laura Hertwig, Sadaf Kalsum, Efthymia Kokkinou, Egle Kvedaraite, Marco Giulio Loreti, Magalini Lourda, Kimia T. Maleki, Karl‐Johan Malmberg, Nicole Marquardt, Christopher Maucourant, Jakob Michaëlsson, Jenny Mjösberg, Kirsten Moll, Jagadees Muva, Johan Mårtensson, Pontus Nauclér, Anna Norrby‐Teglund, Laura M. Palma Medina, Björn Persson, Lena Radler, Emma Ringqvist, John Tyler Sandberg(Karolinska Institutet), Ebba Sohlberg, Tea Soini, Mattias Svensson, Janne Tynell, Renata Varnaitė, Andreas von Kries, Christian Unge, Olav Rooyackers(Karolinska University Hospital), Lars I. Eriksson(Karolinska University Hospital), Jan‐Inge Henter(Karolinska Institutet), Anders Sönnerborg(Karolinska University Hospital), Tobias Allander(Karolinska University Hospital), Jan Albert(Karolinska University Hospital), Morten Nielsen(National University of General San Martín), Jonas Klingström(Karolinska Institutet), Sara Gredmark‐Russ(Karolinska University Hospital), Niklas K. Björkström(Karolinska Institutet), Johan K. Sandberg(Karolinska Institutet), David A. Price(University Hospital of Wales), Hans‐Gustaf Ljunggren(Karolinska Institutet), Soo Aleman(Karolinska University Hospital), Marcus Buggert(Karolinska Institutet)
Cell
August 14, 2020
Cited by 1,987Open Access
Full Text

Abstract

SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. Here, we systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in unexposed individuals, exposed family members, and individuals with acute or convalescent COVID-19. Acute-phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent-phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells were detectable in antibody-seronegative exposed family members and convalescent individuals with a history of asymptomatic and mild COVID-19. Our collective dataset shows that SARS-CoV-2 elicits broadly directed and functionally replete memory T cell responses, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19.


Related Papers